Watson Pharma Private Limited - Due diligence report

A 360° intelligence report on Watson Pharma Private Limited: trust score, financial health, credit view, compliance, directors, growth and d…

2005-10-21 Mumbai, Maharashtra Active Unlisted Active Compliant
Share
WP Watson Pharma Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Watson Pharma Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
81/100
Trust Score
Low Risk

Watson Pharma Private Limited is assessed as Low Risk with a Trust Score of 81/100. Watson Pharma Private Limited is an active private limited indian non-government company incorporated in 2005, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Watson Pharma Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
81/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
68/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
85/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
85/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
75/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
60/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 85/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 1 open (25.00 cr) · 4 satisfied (8.60 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Hdfc Bank Limited1 48.0 cr
Bank Of Baroda1 48.0 cr
Corporation Bank1 48.0 cr
Standard Chartered Bank2 48.0 cr
Compliance Score: 68/100 Moderate
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Litigation present in 2 court forum(s).
  • 1 auditor resignation(s) filed - latest: S R B C & CO LLP on 2024-10-18.
  • Delayed payments to MSME suppliers disclosed (198 disclosure(s)).
  • 3 active GST registration(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 75/100
NameDIN / PANDesignationAppointedTenureDIN status
NISHANK BHARGAVA 01234567 Director 01/04/2018 6 yrs Approved
HEMANT KUMAR MANILAL MAMANIA 01234567 Director 01/04/2018 6 yrs Approved
Agnieszka Monika Lubkowska 01234567 Director 01/04/2018 6 yrs Approved
Vivek Jugal Kishor Saraf 01234567 Director 01/04/2018 6 yrs Approved
Chandrasekhar Bhagwan Sinha 01234567 Director 01/04/2018 6 yrs Approved
  • 5 directors on the board.
  • No disqualified or deactivated DINs.
  • 4 director exits in 3 years - high churn.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Watson Laboratories Inc
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Watson Laboratories Inc Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 60 · Distress 90
Growth signals & trust indicators
Steady revenue growth: +1.42 over 4 year(s).
Operating for 20+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
1 open charge(s) registered - assets are encumbered.
1 auditor resignation(s) on record - review the stated reasons.
MSME payment delays disclosed - latest outstanding 67.19 Lakh.
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence78/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment81/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 25.00 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view74/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
01 Sep 2025
Last AGM held
Annual general meeting
31 Aug 2025
Director ceased
Chandrasekhar Bhagwan Sinha
08 Aug 2025
Director appointed
Chandrasekhar Bhagwan Sinha (Director)
31 Mar 2025
Latest balance sheet
Filed with ROC
28 Aug 2024
Director ceased
Agnieszka Monika Lubkowska
30 Jun 2024
Director ceased
Mehul Dipak Dalal
26 Jun 2024
Director appointed
Agnieszka Monika Lubkowska (Director)
22 Aug 2023
Director ceased
MICHIEL HANS LEONARD WISBRUN
17 Aug 2022
Director ceased
NISHANK BHARGAVA
Director ceased
HEMANT KUMAR MANILAL MAMANIA
24 Feb 2022
Director appointed
NISHANK BHARGAVA (Director)
03 Jan 2022
Director appointed
HEMANT KUMAR MANILAL MAMANIA (Director)
31 Aug 2021
Director ceased
PRAMOD RAMCHANDRA GHORPADE
19 Aug 2021
Director ceased
LIRON WEISS BAZAK
04 Jan 2021
Director ceased
BIJU ABRAHAM PHILIP
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Net worth is positive.
5 active director(s) / partner(s); board looks stable and experienced.
3 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Sakataindia U24117RJ1994PTC008294 Bhiwadi, Rajasthan, India
Zuventus Healthcare U85320PN2002PLC018324 Pune City, Maharashtra, India
Airwaterindia U74900WB2014FTC203939 Kolkata, West Bengal, India
Metrochem Api U24239TG2002PTC039223 Hyderabad, Telangana, India
Sajjan India U51900MH1983PLC030874 Mumbai, Maharashtra, India
Itw India U32301HR1979PTC038643 Ballabgarh, Haryana, India
Neon U24100MH1982PLC027493 Mumbai, Maharashtra, India
Archroma International (India) Private Limited U20119MH2001PTC131020 Mumbai, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Watson Pharma Private Limited before audits and certifications: compliance score 68/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Watson Pharma Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 85/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 60/100, margin trends, ownership structure and peer set for Watson Pharma Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 81/100, distress signals and MSME payment-delay disclosures - know whether Watson Pharma Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Watson Pharma Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Watson Pharma Private Limited an active company?

Watson Pharma Private Limited has MCA status “Active” with a compliance score of 68/100 (Moderate).

Is Watson Pharma Private Limited financially healthy?

Watson Pharma Private Limited has a Financial Health Score of 85/100 (Low Risk) based on its filed financial statements.

Should I do business with Watson Pharma Private Limited?

Its overall Trust Score is 81/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Watson Pharma Private Limited?

The ultimate holding entity is Watson Laboratories Inc. 5 active director(s) are on record.

Does Watson Pharma Private Limited have loans or charges against its assets?

1 open charge(s) are registered against its assets, and 4 earlier charge(s) stand satisfied.

Is Watson Pharma Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 68/100 (Moderate).

Is it risky to lend to Watson Pharma Private Limited?

Its Credit Risk Score is 85/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.